American Heart Association statement: cannabis has cardiovascular risks that outweigh uncertain benefits

The American Heart Association issued its first scientific statement on cannabis and cardiovascular health, concluding that potential cardiovascular harms outweigh uncertain therapeutic benefits.

Page, Robert L et al.·Circulation·2020·Strong EvidenceReview
RTHC-02762ReviewStrong Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

The AHA scientific statement reviewed evidence that cannabis use is associated with cardiovascular risks including tachycardia, arrhythmias, myocardial infarction, stroke, and heart failure, many mediated by delivery mechanism (especially smoking). Few cardiovascular therapeutic benefits were identified. The statement called for reclassification of cannabis from Schedule 1 to enable more research.

Key Numbers

Published in Circulation (impact factor ~29); covers 25+ years of expanding legalization; calls for reclassification from Schedule 1 to facilitate research.

How They Did This

AHA Scientific Statement (expert consensus review) critically reviewing clinical, epidemiological, and policy literature on cannabis and cardiovascular health from medical and public health perspectives.

Why This Research Matters

This is the first formal position statement on cannabis from the nation most influential cardiovascular organization. It sets the tone for how cardiologists should counsel patients and how research priorities should be directed.

The Bigger Picture

With cannabis use increasing rapidly, especially among young people, the AHA is signaling that cardiovascular medicine can no longer ignore cannabis. The call for reclassification reflects the tension between the need for evidence and the legal barriers to obtaining it.

What This Study Doesn't Tell Us

Scientific statement format (expert consensus, not systematic review); much of the underlying evidence is observational; cardiovascular effects of different cannabis products and delivery methods are not well differentiated.

Questions This Raises

  • ?Would non-smoked cannabis products carry fewer cardiovascular risks?
  • ?Should patients with cardiovascular disease be formally counseled against cannabis use?

Trust & Context

Key Stat:
First AHA scientific statement on cannabis: cardiovascular risks outweigh benefits
Evidence Grade:
Strong: AHA scientific statement published in Circulation, representing expert consensus from a leading cardiovascular organization.
Study Age:
Published 2020.
Original Title:
Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.
Published In:
Circulation, 142(10), e131-e152 (2020)
Database ID:
RTHC-02762

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does the American Heart Association say about cannabis?

Their first-ever scientific statement concluded that cannabis cardiovascular risks (including arrhythmia, heart attack, and stroke) outweigh the uncertain therapeutic benefits, and called for reclassification to enable better research.

Is cannabis bad for the heart?

According to the AHA, cannabis use is associated with several cardiovascular risks, many related to smoking as the delivery method. The full risk profile of non-smoked cannabis products is less clear.

Read More on RethinkTHC

Cite This Study

RTHC-02762·https://rethinkthc.com/research/RTHC-02762

APA

Page, Robert L; Allen, Larry A; Kloner, Robert A; Carriker, Colin R; Martel, Catherine; Morris, Alanna A; Piano, Mariann R; Rana, Jamal S; Saucedo, Jorge F. (2020). Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.. Circulation, 142(10), e131-e152. https://doi.org/10.1161/CIR.0000000000000883

MLA

Page, Robert L, et al. "Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.." Circulation, 2020. https://doi.org/10.1161/CIR.0000000000000883

RethinkTHC

RethinkTHC Research Database. "Medical Marijuana, Recreational Cannabis, and Cardiovascular..." RTHC-02762. Retrieved from https://rethinkthc.com/research/page-2020-medical-marijuana-recreational-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.